UNDERSTANDING TOWARDS RHEUMATOID ARTHRITIS WITH THE HELP OF "REPERTORY TO THE RHEUMATIC REMEDIES BY HERBERT A.ROBERTS

TO EVALUATE THE CLINICAL UTILITY OF "REPERTORY TO THE RHEUMATIC REMEDIES" BY HERBERT A.ROBERTS IN CASES OF RHEUMATOID ARTHRITIS

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052631

Enrollment

Registered

2023-05-15

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention1: HOMOEOPATHIC REMEDY: POTENCY DOSE AND REPETITION OF MEDICINE WILL BE DONE AS PER REQUIREMENT OF CASE MEDICINE WILL BE GIVEN ORALLY Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS OF ALL RACES AND RELIGIONS WILL BE INCLUDED PATIENTS WITH POSITIVE DIAGNOSTIC CRITERIA WILL BE INCLUDED PATIENTS OF ALL TYPES OF SOCIOECONOMIC STATUS WILL BE INCLUDED

Exclusion criteria

Exclusion criteria: PATIENTS OF AGE BELOW 25YEARS AND ABOVE 75YEARS CASES THAT NEED SURGICAL INTERVENTION CASES WITH SEVERE COMPLICATION

Design outcomes

Primary

Measure	Time frame
DAS 28 SCORE OF RHEUMATOID ARTHRITIS BY AMERICAN COLLEGE OF RHEUMATOLOGYTimepoint: FOLLOW UP WILL BE TAKEN ON 7 15 OR 21 DAYS AS PER CASE REQUIREMENT	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactPRAJAPATI SAURABH JAGDISHKUMAR

Dr V H Dave Homeopathic Medical College

DR.MEERASHAH@YAHOO.COM9898692003

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026